Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now has funded $25,395,277 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 167 grants at over 100 hospitals in 29 countries.

McGill University - $100,000
$100,000.00
October 2024
Understanding tumor heterogeneity and characterizing treatment responses in ACVR1-mutated diffuse midline gliomas.

Cincinnati Children’s Hospital Medical Center - $200,000
$200,000.00
October 2024
Combining FLASH and immunotherapy to target medulloblastoma relapse

Emory University / Cincinnati Children's Hospital – $93,250
$93,250.00
March 2024
SUMOylation as a novel therapeutic target in DIPG

University of Chicago Medical Center / Washington University St. Louis – $100,000
$100,000.00
December 2023
Characterizing and Targeting ABL1 and ABL2 in Medulloblastoma Leptomeningeal Dissemination.

Icahn School of Medicine at Mount Sinai – $100,000
$100,000.00
December 2023
Targeting macrophages to improve the survival of DIPG

Children’s Cancer Institute – $50,000
$50,000.00
December 2023
A novel formulation to allow the simultaneous targeting of MYCN expression and copper chelation to treat DIPG tumour and overcome multidrug resistance.

Children’s Hospital Colorado – $100,000
$100,000.00
December 2023
Dual targeting processive transcription for Myc-driven circuitry in medulloblastoma.

University of Newcastle – $116,997 USD, 173,016 AUD
$116,997.00
December 2023
(2023) Enhancing the recruitment of tumor infiltrating lymphocytes to improve responses to DMG therapies.

Princess Máxima Center for Pediatric Oncology – $98,306
$98,306.00
December 2023
Assessing the potential of the HDAC inhibitor givinostat ± radiotherapy for the treatment of diffuse midline glioma.

Nemours Children’s Hospital - $50,000
$50,000.00
December 2023
Treatment of Diffuse Intrinsic Pontine Glioma with the Oncolytic Zika Virus.

Icahn School of Medicine at Mount Sinai - $100,000
$100,000.00
December 2023
Preclinical evaluation of TP-0184 in an autochthonous mouse model of DIPG/DMG

The University of Alabama at Birmingham – $100,000
$100,000.00
December 2023
Intranasal Delivery of Targeting Nanotherapeutics for DIPG

Funding of PBTCF 2023 - $25,000
$25,000.00
December 2023

Children's Cancer Institute – $181,736 USD, $281,691 AUD
$181,736.00
November 2023
Targeting post-translational protein modification to halt Diffuse Intrinsic Pontine Glioma tumorgenicity

Memorial Sloan Kettering Cancer Center – $100,000
$100,000.00
November 2023
CSF Cell-free Tumor DNA (CSF cfDNA) Liquid Biopsies for Pediatric, Adolescent, and Young Adult Patients with Primary Brain Tumors